Why Bitcoin Mining Company TeraWulf Shares Are Rising Today
TeraWulf Inc Ordinary Shares WULF | 0.00 |
TeraWulf Inc. (NASDAQ:WULF), which owns and operates vertically integrated, domestic Bitcoin mining facilities, provided a business update on Thursday.
The company reported a fully funded 7.9 EH/s expansion, increasing self-mining capacity by 58%.
With Building 3 at Lake Mariner fully operational, the facility's bitcoin mining infrastructure capacity has increased to approximately 160 MW, the company said in a press release.
The company also announced the expansion of the existing high-performance computing project supporting generative AI and large language model applications at the Lake Mariner facility, planned for 2024.
"Opportunistic market conditions have caused us to reassess our original conservative strategy and opt for a more near-term growth strategy," stated Paul Prager, Co-founder and CEO of TeraWulf.
"With Building 3 completed ahead of schedule and construction for Building 4 already underway, now is the time to charge hard into the upcoming halving and beyond."
The company said that planning is underway for additional growth at Lake Mariner, with the construction of Building 4 having already begun.
In addition to Lake Mariner's growth, TeraWulf also has the option to add an additional 50 MW of bitcoin mining capacity at the nuclear-powered Nautilus Cryptomine facility, bringing the company's capacity at the site to a total of 100 MW.
The company also announced expansion of existing HPC project supporting generative AI planned for 2024.
Price Action: WULF shares are trading higher by 10.07% to $3.1699 on the last check Thursday.
Photo via Company
Recommend
- Benzinga News 07/11 21:05
Surrozen Appoints Andrew Maleki CFO, Effective Nov. 12, Succeeding Charles Williams
Benzinga News 07/11 21:14Cannabix Technologies announces Non-Brokered LIFE Private Placement
Reuters 07/11 21:30Penske Automotive Group (PAG): Reassessing Valuation After Q3 Results and New Capital Plans
Simply Wall St 07/11 21:31Replimune Presents New IGNYTE Trial Data Showing RP1 Plus Nivolumab Reverses Resistance To PD-1 Blockade And Delivers Durable Responses In Advanced Melanoma
Benzinga News 07/11 21:49Will VNET Group’s (VNET) Green REIT Launch Reshape Its Approach to Capital Efficiency and Growth?
Simply Wall St 07/11 22:36Telsey Advisory Group Maintains Outperform on Holley, Raises Price Target to $5
Benzinga News 07/11 23:02A Look at TeraWulf (WULF) Valuation Following $9.5B Fluidstack Joint Venture and Strategic AI Partnerships
Simply Wall St 08/11 21:28


